James Waisman
Medical Oncology · Duarte, CANPI 1356391270
Payments from drug & device makers
Across 53 payments — averaging $9544.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Puma Biotechnology, Inc.$269K
- Merck$229K
- Taiho Oncology, Inc.$4K
- Novartis$3K
- Gilead$41
- AstraZeneca$36
- plus $114 from 4 others
What the payments were for
- Consulting fees$5,96177%
- Food & beverage$7049%
- Education$120%
- Other$1,09814%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Puma Biotechnology, Inc. | 18 | $269,492 |
| Merck | 5 | $228,589 |
| Taiho Oncology, Inc. | 4 | $4,259 |
| Novartis | 16 | $3,304 |
| Gilead | 3 | $41 |
| AstraZeneca | 2 | $36 |
| Amgen | 2 | $35 |
| Stemline Therapeutics Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Foundation Medicine, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$505,835 in reported general payments places this provider in the 70th percentile of 379 medical oncology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 16 | $309 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Duarte
- Marwan FakihDuarte$24.2M
- Sumanta PalDuarte$15.9M
- Daneng LiDuarte$12.4M
- Tanya DorffDuarte$8.7M
- Erminia MassarelliDuarte$7.2M
- Joseph ChaoDuarte$4M
- Karen ReckampDuarte$3.1M
- Yan XingDuarte$2.8M
- Adam RockDuarte$2.7M
- Marianna KoczywasDuarte$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.